Humira (adalimumab) has finally lost its position as the bestselling drug in the world, but it took a pandemic to finally unseat it from the number one spot.
Despite sales of the anti-TNF blockbuster continuing to grow throughout the year, AbbVie Inc.’s product was overtaken by